Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medwave seeks US OK for new BP technology:

This article was originally published in Clinica

Executive Summary

Medwave has submitted to the US FDA a 510(k) marketing application for its noninvasive blood pressure monitoring system, Primo. The product, which can obtain a blood pressure reading in around 15 seconds, produces readings comparable to an invasive catheter. It features an "intuitive" design that promotes ease of use applications, claimed the Danvers, Massachusetts firm, adding that the monitor provided cost benefits for caregivers in that there is no need for calibration for the life of the product. Medwave believes that Primo could address markets worth around $600m in annual revenue.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT058166

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel